'...and subB2M had more promising prospects.'
Problem most of us probably have is there is little to no statistically-significant data/evidence that demonstrates the current unilateral Sub2M-direction is far outweighed by not running with both streams (BARD1 & Sub2M), my point, as far as I can tell in my research/reading, this 'undeniable' statistical-evidence is not present, leading me to believe it's more about the 'ego's' that came across with SDX, than the competition of alternative scientific approaches...
Is it was so compelling, why have we seen very little in the way of actually revenue/sales of any Sub2M product-line..??
'...and subB2M had more promising prospects.'Problem most of us...
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
61.0¢ |
Change
0.020(3.39%) |
Mkt cap ! $67.26M | |||
| Open | High | Low | Value | Volume |
| 58.0¢ | 61.0¢ | 58.0¢ | $56.05K | 95.11K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2999 | 59.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 61.0¢ | 12999 | 3 |
View Market Depth
| Last trade - 16.10pm 22/07/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |